Pristiq Extended-Release is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Pd-rx Pharmaceuticals, Inc.. The primary component is Desvenlafaxine Succinate.
Product ID | 43063-262_80d9c462-e1a6-58cc-e053-2991aa0a164e |
NDC | 43063-262 |
Product Type | Human Prescription Drug |
Proprietary Name | Pristiq Extended-Release |
Generic Name | Desvenlafaxine Succinate |
Dosage Form | Tablet, Extended Release |
Route of Administration | ORAL |
Marketing Start Date | 2008-05-01 |
Marketing Category | NDA / NDA |
Application Number | NDA021992 |
Labeler Name | PD-Rx Pharmaceuticals, Inc. |
Substance Name | DESVENLAFAXINE SUCCINATE |
Active Ingredient Strength | 50 mg/1 |
Pharm Classes | Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2010-05-12 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021992 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2010-05-12 |
Ingredient | Strength |
---|---|
DESVENLAFAXINE SUCCINATE | 50 mg/1 |
SPL SET ID: | 2388423e-6f29-4da6-a34d-032a1e503488 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
46708-540 | Desvenlafaxine | Desvenlafaxine Succinate |
46708-541 | Desvenlafaxine | Desvenlafaxine Succinate |
46708-542 | Desvenlafaxine | Desvenlafaxine Succinate |
50090-5274 | Desvenlafaxine | Desvenlafaxine Succinate |
50090-5293 | Desvenlafaxine | Desvenlafaxine Succinate |
51991-006 | Desvenlafaxine | Desvenlafaxine Succinate |
51991-311 | Desvenlafaxine | Desvenlafaxine Succinate |
51991-312 | Desvenlafaxine | Desvenlafaxine Succinate |
55700-577 | Desvenlafaxine | Desvenlafaxine Succinate |
50090-4069 | Desvenlafaxine Succinate | desvenlafaxine succinate |
59762-1210 | Desvenlafaxine Succinate | desvenlafaxine succinate |
0008-1210 | Pristiq | desvenlafaxine succinate |
0008-1211 | Pristiq | desvenlafaxine succinate |
0008-1222 | Pristiq | desvenlafaxine succinate |
35356-491 | Pristiq | desvenlafaxine succinate |
43063-262 | Pristiq | desvenlafaxine succinate |
55154-4230 | Pristiq | desvenlafaxine succinate |
55154-4235 | Pristiq | desvenlafaxine succinate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PRISTIQ 88308904 5828994 Live/Registered |
Wyeth LLC 2019-02-20 |
PRISTIQ 78541902 3477940 Live/Registered |
WYETH LLC 2005-01-04 |
PRISTIQ 77200228 3521683 Live/Registered |
WYETH LLC 2007-06-07 |